1157 related articles for article (PubMed ID: 17711899)
1. Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome.
Avcin T; Silverman ED
Lupus; 2007; 16(8):627-33. PubMed ID: 17711899
[TBL] [Abstract][Full Text] [Related]
2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
3. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
5. [Leiden, G20210A mutations in prothrombin gene and antiphospholipid antibodies in systemic lupus erythematosus and antiphospholipid syndrome].
Reshetniak TM; Patrushev LI; Stukacheva EA; Miroshnikov AI; Tikhonova TL; Nasonov EL; Alekberova ZS
Ter Arkh; 2000; 72(5):34-8. PubMed ID: 11109617
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and clinical significance of antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome.
Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Cervera R; Espinosa G; Carmona F; Balasch J; Ordinas A; Ingelmo M
Haematologica; 2000 Jun; 85(6):632-7. PubMed ID: 10870121
[TBL] [Abstract][Full Text] [Related]
7. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal determination of antiphospholipid antibodies in lupus patients without previous manifestations of antiphospholipid syndrome. A prospective study.
de Bandt M; Benali K; Guillevin L; Hachulla E; Job C; Fautrel B; Fournié G; Bonnet C; Fournié B; Le Goff P; Jorgensen C; Meyer O
J Rheumatol; 1999 Jan; 26(1):91-6. PubMed ID: 9918247
[TBL] [Abstract][Full Text] [Related]
9. Ocular manifestations in antiphospholipid syndrome.
Suvajac G; Stojanovich L; Milenkovich S
Autoimmun Rev; 2007 Jun; 6(6):409-14. PubMed ID: 17537387
[TBL] [Abstract][Full Text] [Related]
10. The geoepidemiology of the antiphospholipid antibody syndrome.
Biggioggero M; Meroni PL
Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid syndrome in children.
Avcin T
Curr Opin Rheumatol; 2008 Sep; 20(5):595-600. PubMed ID: 18698184
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
Sarzi-Puttini P; Atzeni F; Carrabba M
Minerva Med; 2003 Apr; 94(2):63-70. PubMed ID: 12858154
[TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
15. The Ped-APS Registry: the antiphospholipid syndrome in childhood.
Avcin T; Cimaz R; Rozman B;
Lupus; 2009 Sep; 18(10):894-9. PubMed ID: 19671789
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
17. The effects of lupus and antiphospholipid antibody syndrome on foetal outcomes.
Nalli C; Iodice A; Andreoli L; Lojacono A; Motta M; Fazzi E; Tincani A
Lupus; 2014 May; 23(6):507-17. PubMed ID: 24763535
[TBL] [Abstract][Full Text] [Related]
18. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
[TBL] [Abstract][Full Text] [Related]
19. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M
Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
[TBL] [Abstract][Full Text] [Related]
20. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
Tarr T; Muzes G; Pitlik E; Lakos G; Csépány T; Soltész P; Zeher M; Szegedi G; Kiss E
Orv Hetil; 2005 Jan; 146(5):203-7. PubMed ID: 15773587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
